Allegheny Health Network Specialists Explore Use of Novel Eye Tracking Technology to Assess Long Lasting COVID related Neurological Problems
Share Article
Doctors at Allegheny Health Network (AHN), led by neurologist Kevin M. Kelly, MD, PhD, are studying use of a novel technology to assess the long term neurological effects of the COVID-19 virus on some patients.
“For months, many of these patients have been advised to ‘just deal with it,’ and that’s not an effective approach,” said Dr. Kelly.
PITTSBURGH (PRWEB)
May 10, 2021
Doctors at Allegheny Health Network (AHN), led by neurologist Kevin M. Kelly, MD, PhD, are studying use of a novel technology to assess the long term neurological effects of the COVID-19 virus on some patients. The research, funded by Neurolign Technologies, is exploring the efficacy of Neurolign’s computerized eye movement tracking goggles for helping to analyze a patient’s oculomotor, vestibular, reaction time and cognitive functions. Dr. Kelly’s colleague, Andrea Synowiec, DO assists in the study by screening potential post-COVID patients at AHN’s Headache Center and referring them to him for further assessment and testing with the Neurolign goggles.